Roche in the news

Roche Launches Antibody Drug for Breast Cancer in IndiaSingle-shot breast cancer drug to cut treatment time by 90% - Roche Pharma launches drug to treat breast cancerGovt of Punjab, Roche Pharma India and Niramai Health Analytix partner to accelerate Breast Cancer managementRoche and Delhi State Cancer Institute (DSCI) partner to strengthen the Cancer Care ecosystem in DelhiNew Hope, Funding Approaches As Roche Brings Evrysdi To IndiaEvrysdi has ushered a new journey of hope for patients living with SMA in India: V Simpson EmmanuelRoche's oral therapy 'Evrysdi' to provide cost-effective alternative against fatal genetic disorder SMA in IndiaRoche launches spinal muscular atrophy treatment drug in India priced at around Rs 6 lakh per bottleAll about antibody cocktail drug to fight COVIDAntibody cocktail out in market at Rs 59k/doseAntibody cocktail launched in IndiaRoche's COVID Antibody Cocktail Can Reduce Hospitalisation By 70 Per Cent: CEO SimpsonCOVID antibody cocktail used to treat Donald Trump now launched in IndiaVaccine allowance of Rs 5,000 for each employee of Roche Pharma IndiaAdditional 45,000 Vials of Covid-19 Drug Tocilizumab Allocated to States: GowdaRoche seeking fast approval of antibody cocktail in India to treat Covid

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin. This website is neither intended nor designed to record or report adverse event information. If you have a suspected side effect or problem to report regarding one of our products, visit us atOR please call the Roche India Safety Unit onor E-mail us at

ContactLocationslinkedinfacebooktwitterinstagramyoutubeAbout RochePersonalised HealthcareSolutionsRoche careersMediaPrivacy policyLegal statement